NorthStar Medical Radioisotopes Receives Electron Beam Accelerators for First-of-its-Kind Advanced Medical Radioisotope Production.
NorthStar, leading the way as the sole U.S. commercial supplier of molybdenum-99 (Mo-99), continues expansion efforts for increased capacity and ongoing reliable supply for diagnostic imaging −
BELOIT, Wis.–(BUSINESS WIRE), 12 May 21, NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for medical imaging and therapeutic applications, announced that it has achieved a major milestone in its efforts to expand U.S. production capacity for the important medical radioisotope, molybdenum-99 (Mo-99). The Company has received two custom-built IBA Rhodotron®TT 300-HE (High Energy) electron beam accelerators at its facility in Beloit, Wisconsin. The accelerators are critical components in a first-of-its-kind commercial-scale process to produce Mo-99, the parent radiois